Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River

Viva Biotech supercharges AI-driven drug discovery with NVIDIA tech

The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology

Evogene narrows focus to AI-driven molecule discovery after major strategic overhaul

Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud

Merck, Mayo Clinic forge AI powerhouse to accelerate drug discovery

Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery

The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research

Iambic taps AI to power multi-year drug discovery deal with Takeda

Lantern Pharma launches AI Center of Excellence in Bengaluru to scale precision drug discovery globally

Pierre Fabre and Iktos team up to accelerate AI-driven cancer drug discovery

Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target

Zealand Pharma taps Denmark’s supercomputer to supercharge drug discovery

Gefion, powered entirely by renewable energy, boasts more than 1,500 NVIDIA GPUs

NVIDIA & Eli Lilly launch $1 billion AI Lab to reinvent drug discovery